Acadia Pharmaceuticals buy UBS Group AG

Summary

This prediction is currently active. The price of Acadia Pharmaceuticals has decreased since the start of the prediction. Compared to the start price this results in a performance of -20.69%. This prediction currently runs until 04.12.26. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this prediction

Performance without dividends (%)

Name	1w	1m
Acadia Pharmaceuticals	-3.200%	-3.200%
iShares Core DAX®	0,44 %	3,03 %
iShares Nasdaq 100	3,82 %	4,07 %
iShares Nikkei 225®	1,15 %	6,90 %
iShares S&P 500	2,37 %	2,68 %